ReviewPharmacoEconomics2001
The cost of HIV treatment and care. A global review.
Review in PharmacoEconomics, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries.PharmacoEconomics · 2011Pooled it
- Machine learning prediction of adolescent HIV testing services in Ethiopia.Frontiers in public health · 2024Article
- Married women pre-marital HIV testing status in Ethiopia: Individual and community level factor analysis.Frontiers in medicine · 2023Article
- Quality of Life of People with HIV/AIDS in Iran: A Systematic Review and Meta-Analysis.Iranian journal of public health · 2020Review
- Economic evaluation studies in the field of HIV/AIDS: bibliometric analysis on research development and scopes (GAPBMC health services research · 2019Article
- The Importance of Improving the Quality of Care Among HIV/AIDS Hospitalizations in Portugal.Frontiers in public health · 2019Article
- Economic impact of HIV/AIDS: a systematic review in five European countries.Health economics review · 2014Article
- The cost of antiretroviral treatment service for patients with HIV/AIDS in a central outpatient clinic in Vietnam.ClinicoEconomics and outcomes research : CEOR · 2014Article
- Assessing user preferences for sexually transmitted infection testing services: a discrete choice experiment.Sexually transmitted infections · 2012Article
- Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later.PharmacoEconomics · 2012Review
- HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.PLoS medicine · 2012Article
- The Direct Medical Costs of Late Presentation (<350/mm) of HIV Infection over a 15-Year Period.AIDS research and treatment · 2012Article
- Determinants of health care costs of HIV-positive patients in the Canary Islands, Spain.The European journal of health economics : HEPAC : health economics in prevention and care · 2010Article
- Quality of life in HIV/AIDS.Indian journal of sexually transmitted diseases and AIDS · 2010Article
- The impact of disease stage on direct medical costs of HIV management: a review of the international literature.PharmacoEconomics · 2010Review
- A review of economic evaluations of darunavir boosted by low-dose ritonavir in treatment-experienced persons living with HIV infection.PharmacoEconomics · 2010Review
- The economic costs and health-related quality of life of people with HIV/AIDS in the Canary Islands, Spain.BMC health services research · 2009Article
- The cost of antiretroviral therapy in Haiti.Cost effectiveness and resource allocation : C/E · 2008Article
- Economic models of antiretroviral therapy: searching for the optimal strategy.PharmacoEconomics · 2006Review
- Cost-effectiveness of highly active antiretroviral therapy in South Africa.PLoS medicine · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review of published studies on the costs of HIV treatment and care describes some of the recent developments that have influenced these costs in industrialised and industrialising countries, especially within the context of changing drug treatments. Some of the different approaches to estimating the economic impact of HIV infection are briefly presented. The methods used to review the literature are described, particularly the criteria of a scoring system that was specifically developed to systematically screen some of the studies identified. The mean review score for studies dealing with direct hospital costs increased significantly (p = 0.003) over the 3 periods analysed (before 1987, 1987 to 1995, and 1996 and beyond), indicating that the overall 'quality' of studies increased over time. All cost estimates, other than those from non-industrialised regions, were converted to 1996 US dollars using country-specific total health expenditure inflaters and country-specific Gross Domestic Product Purchasing Power Parity converters. A summary of hospital cost estimates over time and by region demonstrated that the costs of treating asymptomatic individuals and people with symptomatic non-AIDS increased over the period, but that the costs of treating individuals with AIDS appears to have stabilised since the late 1980s. As fewer studies could be identified on the costs of community and informal care, indirect productivity costs and population cost estimates, and costs of care for children with HIV infection, all of these studies were reviewed without the use of the scoring system. Finally, the discussion explores the evidence on the global costs of HIV in non-industrialised economies and the affordability of HIV treatment and care. Some suggestions for the direction of future HIV costing studies are also presented. A need remains for good quality cost data. Adequate research effort should be directed to improving the scope and quality of information on costs of HIV service provision around the world.
Indexed as
Identifiers
11252543What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.